Intelligence Platform

Patents

Browse 20 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 12102688

Immunomodulatory nanofilaments

Stichting Radboud universitair medisch centrum · Granted Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702461

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory pol

Cue Biopharma, Inc. · Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11696896

Immunomodulatory nanoparticle treatment of brain injury

Northwestern University · Granted Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11571444

Enhancement of MSC immunomodulatory properties by treprostinil

United Therapeutics Corporation · Granted Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10001483

Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulat

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9717827

Immunomodulatory materials for implantable medical devices

The Regents of the University of California · Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618080

Immunomodulatory compounds and treatment of diseases related to an overproduction of infla

OM PHARMA · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557859

Immunomodulatory compositions

Summit (Wales) Limited · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8383665

Immunomodulatory compositions

Summit (Wales) Limited · Granted Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8309527

Immunomodulatory oligonucleotides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148340

Immunomodulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114848

Immunomodulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7915240

Immunomodulatory compounds and treatment of diseases related to an overproduction of infla

OM PHARMA · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7208478

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

The Regents of the University of California · Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6610661

Immunostimulatory polynucleotide/immunomodulatory molecule conjugates

The Regents of the University of California · Granted Tue Aug 26 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6562801

PpGpp and pppGpp as immunomodulatory agents

The Board of Regents of the University of Texas System · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Apr 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6271214

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6194388

Immunomodulatory oligonucleotides

The United States of America · Granted Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6133440

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired